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Informed Consent and AUC: Bare It All. . .
Thomas H. Marwick, MBBS, PHD,* Y. Chandrashekhar, MD,† Jagat Narula, MD, PHD‡ppropriate use criteria (AUC) have become
widely accepted as a means of test selec-
tion, and their application has become an
accepted alternative to other means of
controlling test utilization, such as radiology ben-
efit managers (1). Less widely known is the un-
derlying emphasis on the balance of risk and ben-
efit, “an appropriate imaging study is one in
which the expected incremental information,
combined with clinical judgment, exceeds the ex-
pected negative consequences by a sufficiently
wide margin for a specific indication that the pro-
cedure is generally considered acceptable care and
a reasonable approach for the indication” (2).
This issue of iJACC provides 4 papers that reflect
the application of these criteria and perhaps how
we should perceive them.
AUC are most commonly understood as a
shorthand method for evaluating the adequacy of
decision-making as it pertains to test selection. In
a review of large cohort of patients undergoing
transesophageal echocardiograms (TEE) before
cardioversion for atrial fibrillation, Grewal et al.
(3) report inappropriate use of the test in 3.0%
of patients. Whereas 2.5% suffered stroke, and left
atrial thrombus (or “sludge”) was identified in
8.0% of subjects (especially in those at high stroke
risk [18.0%] and symptomatic patients [14.0%]),
neither stroke nor thrombus were documented in
patients in the inappropriate category. While
these results reassure that AUC are followed for
the selection of atrial fibrillation patients for
TEE, they also presage an era when AUC would
be based on outcomes rather than expert opinion.
Cardiovascular imaging remains a major benefi-
ciary of engineering innovation, and the AUC
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‡Mount Sinai School of Medicine, New York, New York.need to be sufficiently dynamic to incorporate new
developments as they are validated. One such ex-
ample relates to the interaction of echocardiogra-
phy with computed tomography and magnetic
resonance imaging as the former becomes a truly
3-dimensional (3D) technique. This development
will allow echocardiography to fill a role in the
accurate measurement of cardiac structures that
was not feasible in the era of 2-dimensional im-
aging. Tamborini et al. (4) have documented the
utility of 3D echocardiography in the measure-
ment of aortic dimensions in patients undergoing
transcatheter aortic valve replacement. The impli-
cation of this study is that 3D TEE could be rea-
sonably added to transcatheter aortic valve replace-
ment evaluation. The evolution of the indications
for test use will assuredly continue between itera-
tions of AUC, implying that unquestioning pur-
suit of an AUC target of 100% will delay the
clinical application of new methodologies that im-
prove care and save money.
AUCs are based on the premise that an appro-
priate test, when used appropriately, will generate
data that will be of sufficient clinical use to signif-
icantly advance decision making in the clinical
setting. This has generated a debate about what
conditions can be covered in such an exercise and
which test is most appropriate in such a condi-
tion. It is assumed that efficacy is the point of
contention, and not safety. It is also presumed
that all these tests are fairly safe, and both the cli-
nician and the patient are clearly aware of the
risks and benefits. Newer imaging methods and
newer information about older imaging modalities
may upend this assumed equation. It is becoming
clear that some tests, especially those involving ra-
diation, might have risks that may need additional
qualification. In addition, often the clinician and
most certainly the patient may not be completely
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666aware of the cumulative risk of some common
tests, especially when done repeatedly over a pe-
riod of time. Further, even if the clinician is fully
aware, a clear and concise communication to the
patient, in the current informed consent practice,
may remain inadequate. This important issue has
received only passing attention so far (5), and
needs to be explored further.
Two papers in this issue of iJACC address this
topic of informed consent in the context of imag-
ing procedures involving radiation and its read-
ability. To most physicians, the performance of a
noninvasive test is usually considered to be of low
risk, unless it is associated with stress testing.
However, the consequences of long-term exposure
to diagnostic radiation, particularly in patients un-
dergoing serial testing, the young, and especially
women, are becoming matters of concern. In the
European Union, the use of diagnostic radiation
is subject to legislation that mandates that it
should not be used in circumstances where there
are alternative imaging strategies. In the United
States however, no such legislation exists, and the
decision to use radiation for diagnostic use is lim-
ited only by the fiduciary duty of the physician to
select appropriate testing. While most clinicians
are familiar with the assumption of linear risk
without threshold that underlies the “as low as
reasonably achievable” (ALARA) principle, the
reality is that many physicians lack knowledge
about either the amount of radiation exposure
from diagnostic testing or the potential conse-
quences (6). The paper by Paterick et al. (7) em-
phasizes that the principles about disclosure have
moved away from the previous professional stan-
dard of what a reasonable physician would de-
scribe in similar circumstances, to what a reason-
able person would want to know about the
balance of risk and benefit inherent in this deci-
sion. Physicians should be able to discuss reason-
able options regarding diagnosis and treatment, as
well as the degree of benefit in symptomatic pa-
tients (which may involve a discussion about the
improvement of quality of life and survival with
appropriate diagnosis), and in asymptomatic pa-
tients (where the risk is justified on the basis of
refining a prediction of cardiovascular risk).
Consent documentation is a vital component of
this dialogue with the patient regarding risk andbenefit. While the common adage that consent is
a process rather than a document is undoubtedly
true, the reality is that consent documentation
provides an excellent opportunity to lay out risks
and benefits of a procedure in the fashion that
the patient should be able to rehearse and recon-
sider after a physician appointment. Terranova et
al. (8) review the content, organization, construc-
tion, and layout of consent documents from Italy,
the United Kingdom, and the United States.
Based on the fact that patients do not have an
ongoing relationship with the imaging physicians,
and the limited time available for the consent
process (9), not only readability but also under-
standability are vital components of this evalua-
tion are attended to in the paper. As would be
anticipated by most clinicians, they found that the
readability of the original documents was poor.
After revision based upon application of a check-
list, there was improvement in readability, partic-
ularly in sentence shortening as well as a minor
degree of improvement of word complexity. This
improvement of readability was matched by im-
proved description of risks, alternatives, limits,
and disadvantages, and was thought by the pa-
tients to improve comprehension, though it has
been acknowledged that this was also influenced
by numerical literacy, education, and other demo-
graphic characteristics (10).
Much attention in the topic of appropriate use
criteria has focused on test selection. The con-
tents of this issue of iJACC should emphasize to
readers that appropriate use also should most cer-
tainly involve an acknowledgment of risk, and
that we all have work to do in facilitating the un-
derstanding of benefit and risk, which supports
shared decision-making. The medical community
will have to rapidly adapt their consent process to
these newer realities. A well-informed patient,
whose autonomy is acknowledged and respected,
is the foundation of our ability to deliver the ab-
solutely best care, and a well executed and com-
prehensive informed consent process is the cor-
nerstone. It is important that we, as imaging
society, engage in standardizing this process to
enhance our patient care mission. Otherwise we
run the risk of a restrictive legal process that
might dictate burdensome external standards that
would compromise excellence in patient care.
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667We would, therefore, suggest that both the
AUC and the process of informed consent would
need to evolve in this new reality. The new
ground for informed consent process is largely
uncharted and legal calisthenics would affect what
will be considered to be “adequately informed pa-
tients.” Merely listing potential adverse events
would not suffice. It would be necessary to antici-
pate them and explain in sufficiently quantified
and understandable terms what a patient would
need to know to make a thoughtful decision
about his or her care. Physicians take great care to
follow AUC, which seem to be a clearly changing
practice. The current way of emphasizing efficacy
of a test in AUC, instead of a combination ofbefore cardioversion for atrial fibrilla-
tion: implications for appropriateness
erations in the effor
goals. JAMA 2011For example, while one always explains the risk
and benefits of the test being performed, it is rare
that the alternative test strategies are discussed
and why one test was chosen over the other. One
could see ramifications of not discussing the avail-
able choices that might violate the “information
needed for a reasonable person to make a reasonable
decision” standard. Thus, marrying safety of a test
(not an overt emphasis in current AUC since it is
assumed that the physician has already considered
safety before choosing this particular test) into its ef-
ficacy will influence the way we think across the
tests rather than being about a test. The new itera-
tion of AUC might be condition based rather than
test based and this will, hopefully, reflect better infficacy and safety, might need to change as well. our informed consent process too.R E F E R E N C E S
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